ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,493, issued on March 3, was assigned to BASF SE (Ludwigshafen, Germany).

"Method for preparing 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethylsulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one" was invented by Christopher Koradin (Ludwigshafen, Germany), Martin John McLaughlin (Liestal, Switzerland), Roland Goetz (Ludwigshafen, Germany), Rahul Kaduskar (Navi Mumbai, India), Harish Shinde (Navi Mumbai, India) and Guillaume Michel Jacques Garivet (Ludwigshafen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for preparing 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4...